368 related articles for article (PubMed ID: 10922301)
1. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.
Zager RA
Am J Kidney Dis; 2000 Aug; 36(2):238-49. PubMed ID: 10922301
[TBL] [Abstract][Full Text] [Related]
2. Development of liposomal polyene antibiotics: an historical perspective.
Ng AW; Wasan KM; Lopez-Berestein G
J Pharm Pharm Sci; 2003; 6(1):67-83. PubMed ID: 12753730
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack.
Zager RA
Kidney Int; 2000 Jul; 58(1):193-205. PubMed ID: 10886564
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
5. Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death.
Zager RA; Johnson AC; Naito M; Bomsztyk K
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F187-97. PubMed ID: 17942567
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack.
Zager RA
Am J Pathol; 1999 Jun; 154(6):1899-909. PubMed ID: 10362817
[TBL] [Abstract][Full Text] [Related]
7. Liposomal polyene antibiotics.
Ng AW; Wasan KM; Lopez-Berestein G
Methods Enzymol; 2005; 391():304-13. PubMed ID: 15721388
[TBL] [Abstract][Full Text] [Related]
8. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
Obatomi DK; Bach PH
In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
[TBL] [Abstract][Full Text] [Related]
9. The reproductive and developmental toxicity of the antifungal drug Nyotran (liposomal nystatin) in rats and rabbits.
Larson JL; Wallace TL; Tyl RW; Marr MC; Myers CB; Cossum PA
Toxicol Sci; 2000 Feb; 53(2):421-9. PubMed ID: 10696790
[TBL] [Abstract][Full Text] [Related]
10. Study of the toxicity of a new lipid complex formulation of amphotericin B.
Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
[TBL] [Abstract][Full Text] [Related]
11. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture.
Joly V; Saint-Julien L; Carbon C; Yeni P
J Pharmacol Exp Ther; 1990 Oct; 255(1):17-22. PubMed ID: 2213553
[TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
Zhang Z; Diener RM; Lipman JM
Int J Toxicol; 2006; 25(4):285-94. PubMed ID: 16815817
[TBL] [Abstract][Full Text] [Related]
13. Isoflurane alters proximal tubular cell susceptibility to toxic and hypoxic forms of attack.
Zager RA; Burkhart KM; Conrad DS
Kidney Int; 1999 Jan; 55(1):148-59. PubMed ID: 9893123
[TBL] [Abstract][Full Text] [Related]
14. Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular attack.
Zager RA; Sacks BM; Burkhart KM; Williams AC
Kidney Int; 1999 Jul; 56(1):104-17. PubMed ID: 10411684
[TBL] [Abstract][Full Text] [Related]
15. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
16. The effect of oxygen tension on the cytotoxicity of hydroquinone and selected hydroquinone metabolites to isolated rat renal proximal tubular cells.
Boatman RJ; English JC; Guerin TS; Cummings LM
Arch Toxicol; 2004 Aug; 78(8):443-52. PubMed ID: 15083269
[TBL] [Abstract][Full Text] [Related]
17. P glycoprotein-mediated cholesterol cycling determines proximal tubular cell viability.
Zager RA
Kidney Int; 2001 Sep; 60(3):944-56. PubMed ID: 11532089
[TBL] [Abstract][Full Text] [Related]
18. Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance".
Zager RA; Burkhart KM; Johnson AC; Sacks BM
Kidney Int; 1999 Nov; 56(5):1788-97. PubMed ID: 10571787
[TBL] [Abstract][Full Text] [Related]
19. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
Rust DM; Jameson G
Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
[TBL] [Abstract][Full Text] [Related]
20. Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents.
Zager RA; Bredl CR; Schimpf BA
Kidney Int; 1992 Jun; 41(6):1588-94. PubMed ID: 1501413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
